Recursion Pharmaceuticals, Inc.
RXRX
$4.50
$0.184.17%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 54.29% | 10.70% | 68.89% | 51.79% | 10.41% |
| Total Receivables | 871.62% | 755.34% | 1,674.68% | 1,489.08% | -28.73% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -26.91% | -11.13% | -21.46% | 62.73% | 120.95% |
| Total Current Assets | 50.60% | 12.40% | 70.00% | 63.02% | 15.50% |
|
|
|||||
| Total Current Assets | 50.60% | 12.40% | 70.00% | 63.02% | 15.50% |
| Net Property, Plant & Equipment | 13.85% | 23.88% | 67.55% | 94.06% | 32.32% |
| Long-term Investments | 211.28% | 215.56% | 203.73% | 185.99% | -1.32% |
| Goodwill | 211.28% | 215.56% | 203.73% | 185.99% | -1.32% |
| Total Other Intangibles | 845.48% | 793.27% | 915.21% | 821.59% | -13.60% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 120.22% | 67.25% | 161.66% | 137.85% | -10.21% |
| Total Assets | 92.64% | 67.86% | 133.98% | 121.60% | 15.17% |
|
|
|||||
| Total Accounts Payable | 516.59% | 413.40% | 390.44% | 446.75% | -47.01% |
| Total Accrued Expenses | 86.41% | 163.65% | 121.72% | 92.23% | 120.24% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 24.26% | 22.54% | 234.15% | 260.89% | 171.93% |
| Total Finance Division Other Current Liabilities | -5.63% | 20.82% | 9.20% | 53.42% | -22.29% |
| Total Other Current Liabilities | -5.63% | 20.82% | 9.20% | 53.42% | -22.29% |
| Total Current Liabilities | 42.44% | 90.54% | 92.07% | 101.21% | 15.69% |
|
|
|||||
| Total Current Liabilities | 42.44% | 90.54% | 92.07% | 101.21% | 15.69% |
| Long-Term Debt | 1,072.61% | -- | 1,435.57% | -37.87% | -9.86% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -31.62% | -27.02% | 27.95% | 97.14% | 65.14% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 617.97% | 371.24% | 313.61% | 166.41% | -64.59% |
| Total Liabilities | 74.60% | 100.20% | 136.95% | 117.50% | 4.71% |
|
|
|||||
| Common Stock & APIC | 67.75% | 54.00% | 74.88% | 72.86% | 35.38% |
| Retained Earnings | -57.13% | -56.12% | -54.27% | -47.92% | -43.19% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 99.59% | 57.27% | 132.82% | 123.28% | 19.77% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 99.59% | 57.27% | 132.82% | 123.28% | 19.77% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 99.59% | 57.27% | 132.82% | 123.28% | 19.77% |
|
|
|||||